SCHEMBL7994596

SCHEMBL7994596

CCCCCCCCCCCCNC(=O)C=Cc1ccc(-c2[nH]c(-c3cccnc3)nc2-c2ccc(OCC(=O)O)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SELP P16109 7/20 0.56
▸ SELE P16581 2/20 0.55
▸ MEN1 O00255 3/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ EGFR P00533 1/20 0.45
▸ HDAC3 O15379 4/20 0.42
▸ HDAC1 Q13547 4/20 0.42
▸ HDAC2 Q92769 4/20 0.42
▸ NCOR2 Q9Y618 3/20 0.42
▸ NAMPT P43490 1/20 0.42
▸ MPO P05164 1/20 0.42
▸ HDAC4 P56524 1/20 0.42
▸ HDAC7 Q8WUI4 1/20 0.42
▸ HDAC10 Q969S8 1/20 0.42
▸ HDAC11 Q96DB2 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7994592 1.00 SELP (0.56) SELPSELEMEN1KMT2ACYP3A4
SCHEMBL7995566 0.91 SELP (0.53) SELPSELEMEN1KMT2ACYP3A4
SCHEMBL7995569 0.91 SELP (0.53) SELPSELEMEN1KMT2ACYP3A4
SCHEMBL7994595 0.89 SELP (0.55) SELPSELEMEN1KMT2ACYP3A4
SCHEMBL7993959 0.89 SELP (0.68) SELPSELEMEN1KMT2ACYP3A4
SCHEMBL7982779 0.89 SELP (0.68) SELPSELEMEN1KMT2ACYP3A4
SCHEMBL8193669 0.88 SELP (0.59) SELPSELEEGFRHDAC3HDAC1
SCHEMBL8193662 0.88 SELP (0.59) SELPSELEEGFRHDAC3HDAC1
SCHEMBL8194911 0.86 SELP (0.58) SELPSELEMEN1KMT2ACYP3A4
SCHEMBL8194916 0.86 SELP (0.58) SELPSELEMEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000033836-A1 5-MEMBERED HETEROCYCLES FOR THE TREATMENT OF HUMAN DISEASES INVOLVING MODULATORS OF SELECTINS ONTOGEN CORPORATION (US) 2000-06-15 — — WO claimed
WO-2000033836-A9 5-MEMBERED HETEROCYCLES FOR THE TREATMENT OF HUMAN DISEASES INVOLVING MODULATORS OF SELECTINS ONTOGEN CORP (US) 2001-10-04 — — WO disclosed
WO-2000033836-A1 5-MEMBERED HETEROCYCLES FOR THE TREATMENT OF HUMAN DISEASES INVOLVING MODULATORS OF SELECTINS ONTOGEN CORPORATION (US) 2000-06-15 — — WO disclosed
Send feedback